Decreased expression of microRNA-130a correlates with TNF-α in the development of osteoarthritis

Zeng-Chun Li1, Ning Han1, Xin Li1

  • 1Department of Emergency Trauma Surgery, East Hospital, Tongji University School of Medicine Shanghai 200120, China.

Abstract

Insights

MicroRNA-130a (miR-130a) regulates tumor necrosis factor-alpha (TNF-α) in osteoarthritis. Decreased miR-130a and increased TNF-α are linked to OA, suggesting miR-130a as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Immunology
  • Biochemistry

Background:

  • Osteoarthritis (OA) is a joint disease characterized by inflammation.
  • Tumor necrosis factor-alpha (TNF-α) is a key inflammatory mediator in OA.
  • The role of microRNAs (miRNAs) in regulating TNF-α in OA remains unclear.

Purpose of the Study:

  • To investigate the regulatory role of miRNAs in TNF-α expression in human chondrocytes.
  • To explore the potential of miR-130a as a therapeutic target for OA.

Main Methods:

  • Examined miRNA-130a and TNF-α expression in OA patient cartilage and chondrocytes.
  • Utilized siRNA for gene silencing in chondrocytes.
  • Analyzed gene and protein expression using real-time PCR and western blotting.

Main Results:

  • OA tissues showed decreased miRNA-130a and increased TNF-α.
  • A negative correlation was observed between miRNA-130a and TNF-α levels.
  • Loss of miRNA-130a function enhanced TNF-α expression and chondrocyte inflammation.
  • miRNA-130a dysfunction contributes to OA pathogenesis and bone metabolism abnormalities.

Conclusions:

  • miR-130a plays a crucial role in regulating TNF-α expression in human chondrocytes.
  • miR-130a represents a novel therapeutic target for osteoarthritis.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.1K